Leon Wang is Executive Vice President, International and China President at AstraZeneca. He is responsible for the overall strategy for the region and for driving sustainable growth across our activities in China, Asia Area, Australia, New Zealand, as well as Latin America, Brazil, Russia, Eurasia, the Middle East and Africa. As a member of AstraZeneca’s Senior Executive Team, Mr Wang reports to the CEO, Pascal Soriot.
Mr Wang joined AstraZeneca China in March 2013 as Vice President for GI, Respiratory, Anaesthesia and Antiinfection (GRA), and was promoted to President of AstraZeneca China in 2014. Under Mr Wang’s leadership, China has become AstraZeneca’s second-largest market worldwide, and AstraZeneca has become one of the fastest-growing multinational pharmaceutical companies in China. In January 2017, Mr Wang was promoted to Executive Vice President, Asia Pacific Region at AstraZeneca, with responsibility for the strategy and sustainable growth of businesses in China, Asia Area, Australia and New Zealand. In May 2017, Mr Wang further expanded his role to cover the whole international region as Executive Vice President.
As a local leader, Mr Wang grew up, studied, and developed his career in Shanghai, and he is devoted to the long-term development of AstraZeneca’s business in China as well as the nation’s pharmaceutical industry.
During his tenure, Mr Wang has advocated and driven the commercial innovation strategy in China. Focusing on the core company value of ‘Putting Patients First’, he has led the company’s efforts to establish strategic collaboration with cross-border partners, to provide innovative integrated diagnosis-and-treatment solution covering the entire patient journey and help for establishing an innovative healthcare ecosystem in the industry.
With twenty years of extensive management experience in the pharmaceutical industry, including a series of positions of increasing responsibility in marketing and business leadership at Roche, where he was a Business Unit Vice President before joining AstraZeneca, Mr Wang has developed deep and unique insights into China’s healthcare and pharmaceutical industries.
In addition, Mr Wang holds several positions in local trade associations and other prominent organizations. These include Member of the 12th Jiangsu Provincial Committee of the Chinese People’s Political Consultative Conference, Deputy to the 16th Wuxi Municipal People’s Congress, the 8th Rotating President of China Pharmaceutical Enterprise Association, Vice Chairman of the 8 th Council of the Shanghai Association of Enterprises with Foreign Investment.
Mr Wang holds an EMBA from China Europe International Business School, and a Bachelor of Arts from Shanghai International Studies University.